Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


Schizophrenia Trials: Overcoming Methodological Challenges to Enhance Study Success

Add this event to your calendar: iCal   Google Calendar

Who should attend?

Executives, scientists and managers from pharma, biotech and CROs working in CNS drug development, including: Strategic drug development Clinical operations Outsourcing and procurement Clinical trial planning and optimization Clinical scientists Schizophrenia researchers


In this webinar, we will consider methodological improvements associated with recruiting patients into clinical trials, improving patient assessment and retention in trials, the use of cognitive biomarkers to guide decision making about the safety and efficacy of drugs and how to minimize the risk of placebo and practice effects in studies of schizophrenia.




Andrew Juurinen

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.